Drug Type Radiolabeled antibody, Diagnostic radiopharmaceuticals |
Synonyms 131I labeled actuximab, Iodine 131 actuximab, DK-001 |
Target |
Action inhibitors |
Mechanism CEA inhibitors(Carcinoembryonic antigen inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Application |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 1 | China | 13 Jan 2016 | |
| Colorectal Cancer | IND Application | China | 30 Jan 2022 |






